# Literature Summary

Each paper below is one row, with MRI sequences, dataset info, model type, metrics, and augmentation details where reported.

| Paper | Year | Task / Target | MRI sequences used | Dataset (patients / lesions / exams) | Public? | Public dataset link | Split / Validation | Models used | Best-performing model | AUROC | Accuracy | Sensitivity | Specificity | Precision | F1 | Data augmentation (when) | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study](Artificial-intelligence-and-radiologists-in-prosta.pdf) | 2024 | Binary classification: clinically significant PCa (Gleason grade group ≥2) | Biparametric + multiparametric MRI (sequence details not specified in text) | 10,207 MRI exams from 9,129 patients; training/tuning 9,207; testing 1,000; reader study 400 cases | Partially public | https://pi-cai.grand-challenge.org/ | Train/tune vs hidden test; reader study on 400 test cases | Ensemble of top 5 AI models (PI-CAI consortium) | Equal-weighted ensemble AI system | 0.91 (AI vs radiologists 0.86) | — | Reader-reference sensitivity 89.4% at PI-RADS >=3; AI at matched sensitivity had 50.4% fewer false positives | Reader-reference specificity 57.7% at PI-RADS >=3; AI at matched specificity detected 6.8% more csPCa | — | — | Not specified | Public subset of 1,500 cases; full data access via application per paper | 
| [ISUP Grade Prediction of Prostate Nodules on T2WI Acquisitions Using Clinical Features, Textural Parameters and Machine Learning-Based Algorithms](cancers-17-02035.pdf) | 2025 | Binary classification: ISUP 1 vs 2–5; ISUP 2 vs 3 | T2-weighted imaging used for radiomics (mpMRI protocol includes T2, T1, DWI/ADC, DCE) | 154 patients; 201 lesions; single-center | No (contact authors) | — | 70/30 train/test split | Random Forest, SVM, Logistic Regression (clinical, radiomic, combined) | Random Forest (partial correlation) with combined clinical + radiomics | — | 91.11% (ISUP 1 vs 2–5); 91.39% (ISUP 2 vs 3) | — | — | — | — | Random oversampling of ISUP 3 in per-ISUP analysis (training) | T2WI-only radiomics for modeling; reported lower accuracies without clinical data (88.13% and 82.5%) |
| [Radiomics based Machine Learning Models for Classification of Prostate Cancer Grade Groups from Multi Parametric MRI Images](JMSS-14-33.pdf) | 2024 | Multiclass classification: 5 Gleason Grade Groups | T2W, ADC, high b-value DWI | 203 patients | No (private retrospective cohort) | — | 80/20 train/test split | Feature selection (mRMR, RFE) + 6 ML classifiers | RFE + Random Forest on high b-value DWI | 0.98 (average) | 97.0% | 98.0% | — | 98.0% | 97.0% | SMOTE oversampling (training) | Reported performance for 5-class grading |
| [Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network](s00330-019-06417-z.pdf) | 2020 | Binary classification: clinically significant PCa (Gleason ≥7) | T2w, ADC, DWI, K-trans (from DCE) | 200 patients; 318 lesions (PROSTATEx) | Yes | https://prostatex.grand-challenge.org/ | 175 train / 25 test; 8-fold cross-validation | 3D CNN with multi-sequence inputs | ADC + DWI + K-trans input combo | 0.897 (avg) | — | 88.6% | 90.0% | — | — | Not specified | Public PROSTATEx challenge dataset |
| [Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images](s41598-022-06730-6.pdf) | 2022 | Detection + segmentation + GGG estimation; binary significance GGG ≥2 | ProstateX: T2, DW (b50/b400/b800), ADC, Ktrans (DCE); IVO: T2, DW (b100/b500/b1000/1400), ADC, DCE T1 series | 490 train/val mpMRIs; 75 test (45 ProstateX, 30 IVO) | Mixed (ProstateX public; IVO private) | https://prostatex.grand-challenge.org/ | 5-fold CV on train/val; held-out test | 3D Retina U-Net pipeline (detection + segmentation) | Retina U-Net + multi-sequence input | 0.96 (ProstateX lesion); 0.95 (IVO lesion) | — | 1.00 (lesion, GGG ≥2) | 0.79 (ProstateX), 0.80 (IVO) | — | — | Online 3D augmentation + Random Channel Drop (training) | Patient-level AUC 0.87 (ProstateX), 0.91 (IVO) |
| [Enhanced ISUP grade prediction in prostate cancer using multi-center radiomics data](s41598-025-04858-3.pdf) | 2025 | Multiclass ISUP grade prediction (0–5) | T2WI, DWI, ADC (bpMRI; no DCE) | 1500 patients (PI-CAI multi-center dataset) | Yes | https://pi-cai.grand-challenge.org/DATA/ | 85% train / 15% test; no external validation | Radiomics + Random Forest | Combined Peripheral Zone + Central Gland Random Forest model | 0.928 | 0.722 | 0.767 (reported as recall) | Not reported | 0.681 | Not reported | SMOTE applied to training set only | Large multi-center dataset; 12,918 radiomic features; anatomical ROI-based modeling |
